dna double helix whitecross white 2 másolat

              THE WHITE CROSS         P & C LLP.

The Biotech R&D Supporter

“THE WHITE CROSS PRODUCTION & COMMERCIAL LLP” was founded with a clear vision: to expand access to the expertise required for the manufacture and distribution of high-quality biologic medicines, leveraging a solid scientific foundation in North America and Europe, as well as world-class manufacturing processes. Building on its decades of expertise in complex fermentation research technologies, the company launched a long-term strategic investment initiative in the field of biotechnology in 2024, as the successor to several smaller private research institutions, in collaboration with numerous partners in Europe, South Asia, and Southeast Asia; this investment has since evolved into a fully integrated, innovation-driven, global research and development business unit.
 

“THE WHITE CROSS PRODUCTION & COMMERCIAL LLP” aims to become a widely recognized international biotechnology company whose therapeutic activities focus primarily — though not exclusively, as our research support programs are also shaped by our partners’ needs — on oncology, rheumatology, immunology, osteoporosis, and thyroid diseases, through which we aim to continue fully meeting the needs of our business and research partners. The company is engaged in the research of safe, effective biosimilar medicines and supports its partners in both development and commercialization, while maintaining a sustainable R&D portfolio based on the real needs of patients and physicians.
 

The comprehensive professional capabilities of the company’s in-house and contracted staff—ranging from research and development and analytics through mammalian and microbial manufacturing support to the production of finished drug products—ensure reliability, flexibility, and consistency at every step of the value chain.
 

As healthcare systems worldwide face growing demand for biologics and increasing supply challenges, the development and manufacturing support network of "THE WHITE CROSS PRODUCTION & COMMERCIAL LLP" Biotechnology Division’s development and manufacturing support network provides flexibility, security, and high scientific standards to its partners. Our research partners operate state-of-the-art, GMP-certified facilities, complemented by long-term research and pilot manufacturing activities, forming a solid technological foundation supported by international regulatory approvals, strategic collaborations with global partners, and the expertise of numerous biotechnology specialists.
 

With its commitment to affordable prices, quality, and patient-centered solutions, "THE WHITE CROSS PRODUCTION & COMMERCIAL LLP" enables earlier access to advanced therapies through its own research and experimental-phase therapeutic care, helps improve quality of life, and supports sustainable healthcare budgets.

It is no coincidence that our slogans are: Quality Research, Professional Perfectionism, Reliable Science, Accessible Care.
 

If, in addition to our general and aforementioned biotechnology activities, you are also interested in our newly introduced CHC or biosimilar research and information support services, we look forward to hearing from you, and our expert colleagues will inform you about the possible parameters of collaboration.

bg-black

ABOUT US

THE COMPANY and Company's Divisions


"THE WHITE CROSS PRODUCTION & COMMERCIAL LLP" is a Canadian-registered company founded in 2024 by founders, as the successor to several smaller private research institutions,  with expertise in various industrial and professional sectors who share common values in their professional commitment, whether in healthcare management, epidemiology, biotechnology and applied technology, logistics and project organization and other areas such as sales support and marketing. 


Based on our experts’ qualifications, skills, and practical knowledge, as well as the needs of our partners and the industry, we have divided our corporate activities into business divisions.

Our primary business division focuses on healthcare and human welfare systems, such as: 
- Biotechnology research and manufacturing support, 
- Medical, Wellness, and other human health-supporting welfare services and product distribution business unit, 
- General medical research and development business unit, 
- Epidemiological services business unit.
 

The management of these services and products requires significant professional human resources, which are represented and delivered at the highest level by both our in-house and contracted colleagues and partners.
 

If you would like to consult with our expert colleagues regarding any of our business activities, please let us know by contacting us via any of the contact details listed on our contact page, and our colleagues will reach out to you immediately with the necessary information.

01111211113000001